Related Experiment Video
Updated: May 9, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Targeting NLRP3 signaling reduces myocarditis-induced arrhythmogenesis and cardiac remodeling
Chye-Gen Chin1,2, Yao-Chang Chen3, Fong-Jhih Lin1,3
1Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei, 11031, Taiwan.
Background:
Myocarditis substantially increases the risk of ventricular arrhythmia. Approximately 30% of all ventricular arrhythmia cases in patients with myocarditis originate from the right ventricular outflow tract (RVOT). However, the role of NLRP3 signaling in RVOT arrhythmogenesis remains unclear.
Methods:
Rats with myosin peptide-induced myocarditis (experimental group) were treated with an NLRP3 inhibitor (MCC950; 10 mg/kg, daily for 14 days) or left untreated. Then, they were subjected to electrocardiography and echocardiography. Ventricular tissue samples were collected from each rat's RVOT, right ventricular apex (RVA), and left ventricle (LV) and examined through conventional microelectrode and histopathologic analyses. In addition, whole-cell patch-clamp recording, confocal fluorescence microscopy, and Western blotting were performed to evaluate ionic currents, intracellular Ca2+ transients, and Ca2+-modulated protein expression in individual myocytes isolated from the RVOTs.
Results:
The LV ejection fraction was lower and premature ventricular contraction frequency was higher in the experimental group than in the control group (rats not exposed to myosin peptide). Myocarditis increased the infiltration of inflammatory cells into cardiac tissue and upregulated the expression of NLRP3; these observations were more prominent in the RVOT and RVA than in the LV. Furthermore, experimental rats treated with MCC950 (treatment group) improved their LV ejection fraction and reduced the frequency of premature ventricular contraction. Histopathological analysis revealed higher incidence of abnormal automaticity and pacing-induced ventricular tachycardia in the RVOTs of the experimental group than in those of the control and treatment groups. However, the incidences of these conditions in the RVA and LV were similar across the groups. The RVOT myocytes of the experimental group exhibited lower Ca2+ levels in the sarcoplasmic reticulum, smaller intracellular Ca2+ transients, lower L-type Ca2+ currents, larger late Na+ currents, larger Na+-Ca2+ exchanger currents, higher reactive oxygen species levels, and higher Ca2+/calmodulin-dependent protein kinase II levels than did those of the control and treatment groups.
Conclusion:
Myocarditis may increase the rate of RVOT arrhythmogenesis, possibly through electrical and structural remodeling. These changes may be mitigated by inhibiting NLRP3 signaling.
Insights
Myocarditis increases ventricular arrhythmia risk, particularly from the right ventricular outflow tract (RVOT). Inhibiting NLRP3 signaling with MCC950 may mitigate these effects by reducing inflammation and abnormal electrical activity.
Area of Science:
- Cardiology
- Immunology
- Electrophysiology
Background:
- Myocarditis significantly elevates the risk of ventricular arrhythmia, with approximately 30% originating from the right ventricular outflow tract (RVOT).
- The specific role of NLRP3 inflammasome signaling in RVOT arrhythmogenesis remains largely unexplored.
Purpose of the Study:
- To investigate the role of NLRP3 inflammasome signaling in myocarditis-induced RVOT arrhythmogenesis.
- To evaluate the therapeutic potential of NLRP3 inhibition in mitigating RVOT arrhythmias.
Main Methods:
- Myocarditis was induced in rats using myosin peptides; experimental groups received the NLRP3 inhibitor MCC950.
- Cardiac function was assessed via electrocardiography and echocardiography.
- RVOT, RVA, and LV tissues underwent histopathological analysis, microelectrode recordings, and myocyte-level investigations (patch-clamp, Ca2+ transients, protein expression).
Main Results:
- Myocarditis led to reduced LV ejection fraction and increased premature ventricular contractions, with heightened NLRP3 expression and inflammation in RVOT/RVA.
- MCC950 treatment improved cardiac function and reduced arrhythmias.
- RVOT myocytes from myocarditis rats showed altered ionic currents, impaired Ca2+ handling, elevated reactive oxygen species, and increased Ca2+/calmodulin-dependent protein kinase II, which were reversed by MCC950.
Conclusions:
- Myocarditis induces electrical and structural remodeling in the RVOT, promoting arrhythmogenesis.
- Inhibition of NLRP3 signaling presents a potential therapeutic strategy to manage RVOT arrhythmias associated with myocarditis.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management

